<table className="table"><caption><p>Screening Guidelines for Prediabetes or Type 2 Diabetes Mellitus in Asymptomatic Adults</p></caption><thead><tr><th colSpan="1" rowSpan="1"><p></p></th><th colSpan="1" rowSpan="1"><p>ADA (2025)</p></th><th colSpan="1" rowSpan="1"><p>USPSTF (2021)</p></th></tr></thead><tbody><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Screening criteria</p></td><td colSpan="1" rowSpan="1"><p>Screen adults with overweight (BMI ≥25, or ≥23 in persons of Asian ancestry) with at least one additional risk factor:</p><p>First-degree relative with diabetes</p><p>Race/ethnicity with high risk (e.g., African American, Latino, Native American, Asian American)</p><p>History of CVD</p><p>Physical inactivity</p><p>Hypertension (≥130/80 mm Hg or receiving antihypertensive therapy)</p><p>HDL cholesterol &lt;35 mg/dL (0.90 mmol/L) and/or triglycerides &gt;250 mg/dL (2.82 mmol/L)</p><p>Polycystic ovary syndrome</p><p>Other conditions associated with insulin resistance (severe obesity, acanthosis nigricans, metabolic dysfunction–associated steatotic liver disease)</p><p>All others: begin testing at age 35 years</p></td><td colSpan="1" rowSpan="1"><p>Screen nonpregnant adults aged 35 to 70 years who have overweight or obesity</p><p>Screening for other modifiable risk factors for CVD</p><p>Overweight</p><p>Obesity</p><p>Physical inactivity</p><p>Hypertension</p><p>Abnormal lipid levels</p><p>Smoking</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Additional screening considerations</p></td><td colSpan="1" rowSpan="1"><p>Persons with HIV infection, exposure to high-risk medications, evidence of periodontal disease, or history of pancreatitis</p></td><td colSpan="1" rowSpan="1"><p>Consider screening earlier if one of the following risk factors is present:</p><p>Family history of diabetes</p><p>History of gestational diabetes</p><p>Polycystic ovary syndrome</p><p>BMI ≥23 in Asian Americans</p><p>Race/ethnicity with high risk (Black, Hispanic/Latino, Asian American, American Indian/Alaskan Native, Native Hawaiian/Pacific Islander)</p></td></tr><tr className="group_1-3 row-odd"><td colSpan="1" rowSpan="1"><p>Screening intervals</p></td><td colSpan="1" rowSpan="1"><p>Rescreen at least every 3 years if results are normal</p><p>Monitor patients with a history of prediabetes annually</p><p>Test patients with a history of gestational diabetes every 1-3 years</p></td><td colSpan="1" rowSpan="1"><p>Data supporting optimal screening intervals are limited. Rescreening every 3 years may be reasonable.</p></td></tr></tbody></table>